Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc.（RXDX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RXDX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
12
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Prometheus Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
RXDX 季度内部人买卖趋势
RXDX 内幕交易卖出 · RXDX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
RXDX 高管卖出股份 · RXDX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 16, 2023 | Hendrix Martin Director | Other | 2,071 | $414K | Form 4 |
| Jun 16, 2023 | Laur James Director | Other | 2,071 | $414K | Form 4 |
| Jun 16, 2023 | Stenhouse Mark COO | Other | 14,000 | $2.80M⚡ | Form 4 |
| Jun 16, 2023 | Szela Mary T Director | Other | 2,071 | $414K | Form 4 |
| Jun 16, 2023 | McKenna Mark C. Chairman, President and CEO · Director | Other | 178,098 | $35.62M⚡ | Form 4 |
| Jun 16, 2023 | Swain Judith L Director | Other | 2,071 | $414K | Form 4 |
| Jun 16, 2023 | PAPA JOSEPH C Director | Other | 10,000 | $2.00M⚡ | Form 4 |
| Jun 16, 2023 | Hassan Fred Director | Other | 2,123 | $425K | Form 4 |
| Jun 16, 2023 | Marshall Keith W CFO | Other | 87,973 | $17.59M⚡ | Form 4 |
| Jun 16, 2023 | Adams Helen C. Director | Other | 2,674 | $535K | Form 4 |
| Jun 2, 2023 | McKenna Mark C. Chairman, President & CEO · Director | Option | 3 | $5 | Form 4 |
| Jun 2, 2023 | McKenna Mark C. Chairman, President & CEO · Director | Option | 122,528 | $355K | Form 4 |
| Jun 2, 2023 | Marshall Keith W CFO | Option | 78,162 | $242K | Form 4 |
| Jun 1, 2023 | Stenhouse Mark COO | Other | 14,000 | — | Form 4 |
| Jun 1, 2023 | Stenhouse Mark COO | Other | 14,000 | — | Form 4 |
| Jun 2, 2023 | PAPA JOSEPH C Director | Other | 10,000 | — | Form 4 |
| Jun 2, 2023 | PAPA JOSEPH C Director | Other | 10,000 | — | Form 4 |
| May 19, 2023 | Szela Mary T Director | Award | 2,071 | — | Form 4 |
| May 19, 2023 | Swain Judith L Director | Award | 2,071 | — | Form 4 |
| May 19, 2023 | PAPA JOSEPH C Director | Award | 2,278 | — | Form 4 |
| May 19, 2023 | Laur James Director | Award | 2,071 | — | Form 4 |
| May 19, 2023 | Hendrix Martin Director | Award | 2,071 | — | Form 4 |
| May 19, 2023 | Hassan Fred Director | Award | 2,123 | — | Form 4 |
| May 19, 2023 | Adams Helen C. Director | Award | 2,174 | — | Form 4 |
| Apr 5, 2023 | Marshall Keith W CFO | Option | 10,000 | $37K | Form 4 |
McKenna Mark C.
Chairman, President and CEO · Director
日期
Jun 16
股数
178,098
均价
$200.00
总金额
$35.62M ⚡
McKenna Mark C.
Chairman, President & CEO · Director
日期
Jun 2
股数
3
均价
$1.70
总金额
$5
McKenna Mark C.
Chairman, President & CEO · Director
日期
Jun 2
股数
122,528
均价
$2.90
总金额
$355K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RXDX 内幕交易
RXDX 内幕交易
Prometheus Biosciences, Inc.（RXDX）内幕交易数据来源于公司内部人（包括RXDX）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。RXDX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Prometheus Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RXDX 内幕交易 · 5个问题Prometheus Biosciences, Inc.（RXDX）的内部人包括高管和董事，如RXDX等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026